Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2009 3
2010 6
2011 7
2012 10
2013 14
2014 14
2015 9
2016 8
2017 12
2018 16
2019 23
2020 19
2021 12
2022 6
Text availability
Article attribute
Article type
Publication date

Search Results

145 results
Results by year
Filters applied: . Clear all
Page 1
Showing results for zhao ying yong
Search for Zhaoyang Kong instead (2 results)
New insights into TGF-β/Smad signaling in tissue fibrosis.
Hu HH, Chen DQ, Wang YN, Feng YL, Cao G, Vaziri ND, Zhao YY. Hu HH, et al. Among authors: zhao yy. Chem Biol Interact. 2018 Aug 25;292:76-83. doi: 10.1016/j.cbi.2018.07.008. Epub 2018 Jul 11. Chem Biol Interact. 2018. PMID: 30017632 Review.
Identification of serum metabolites associating with chronic kidney disease progression and anti-fibrotic effect of 5-methoxytryptophan.
Chen DQ, Cao G, Chen H, Argyopoulos CP, Yu H, Su W, Chen L, Samuels DC, Zhuang S, Bayliss GP, Zhao S, Yu XY, Vaziri ND, Wang M, Liu D, Mao JR, Ma SX, Zhao J, Zhang Y, Shang YQ, Kang H, Ye F, Cheng XH, Li XR, Zhang L, Meng MX, Guo Y, Zhao YY. Chen DQ, et al. Among authors: zhao yy. Nat Commun. 2019 Apr 1;10(1):1476. doi: 10.1038/s41467-019-09329-0. Nat Commun. 2019. PMID: 30931940 Free PMC article.
Metabolomics in nephrotoxicity.
Zhao YY, Lint RC. Zhao YY, et al. Adv Clin Chem. 2014;65:69-89. Adv Clin Chem. 2014. PMID: 25233611 Review.
Metabolomics in dyslipidemia.
Chen H, Miao H, Feng YL, Zhao YY, Lin RC. Chen H, et al. Among authors: zhao yy. Adv Clin Chem. 2014;66:101-19. doi: 10.1016/b978-0-12-801401-1.00004-9. Adv Clin Chem. 2014. PMID: 25344987 Review.
145 results